Muscle-specific receptor tyrosine kinase antibody-positive and seronegative myasthenia gravis

Frontiers of Neurology and Neuroscience

Volumn 26, Issue , 2009, Pages 109-119

  Muppidi, Srikanth ^a   Wolfe, Gil I ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CHOLINERGIC RECEPTOR ANTIBODY; CHOLINESTERASE INHIBITOR; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; IMMUNOGLOBULIN; MUSCLE SPECIFIC RECEPTOR TYROSINE KINASE ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; PROTEIN TYROSINE KINASE; PYRIDOSTIGMINE; RITUXIMAB; UNCLASSIFIED DRUG; CHOLINERGIC RECEPTOR; MUSK PROTEIN, HUMAN;

ANTIBODY DETECTION; BULBAR PARALYSIS; CRANIAL NEUROPATHY; DEMOGRAPHY; DISEASE SEVERITY; DRUG MEGADOSE; ELECTROMYOGRAPHY; EYE DISEASE; HUMAN; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; LIMB; MUSCLE; MUSCLE BIOPSY; MUSCLE WEAKNESS; MYASTHENIA GRAVIS; NECK MALFORMATION; NERVE STIMULATION; PATHOLOGY; PLASMAPHERESIS; PRIORITY JOURNAL; PROGNOSIS; PROVOCATION TEST; RESPIRATORY TRACT DISEASE; REVIEW; SEROLOGY; SEX DIFFERENCE; THYMECTOMY; THYMUS; TONGUE DISEASE; TREATMENT RESPONSE; CLASSIFICATION; IMMUNOLOGY;

HUMANS; MYASTHENIA GRAVIS; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, CHOLINERGIC;

EID: 67649745884     PISSN: 16604431     EISSN: 16622804     Source Type: Book Series    
DOI: 10.1159/000212372     Document Type: Review

References (40)

1. Hoch W, McConville J, Helms S, Newsom-Davis J, Melms A, Vincent A: Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies. Nature Med 2001;7:365-368.
2. Jha S, Xu K, Maruta T, Oshima M, Mosier DR, Atassi MZ, Hoch W: Myasthenia gravis induced in mice by immunization with the recombinant extracellular domain of rat muscle-specific kinase (MuSK). J Neuroimmunol 2006;175:107-117.
3. Chan KH, Lachance DH, Harper CM, Lennon VA: Frequency of seronegativity in adult-acquired generalized myasthenia gravis. Muscle Nerve 2007;36: 651-658.
4. Wolfe GI, Trivedi JR, Oh SJ: Clinical review of muscle-specific tyrosine kinase-antibody positive myasthenia gravis. J Clin Neuromuscul Dis 2007;8: 217-224.
5. Leite MI, Jacob S, Viegas S, Cossins J, Clover L, Morgan B P, Beeson D, Willcox N, Vincent A: IgG 1 antibodies to acetylcholine receptors in 'seronegative' myasthenia gravis. Brain 2008;131:1940-1952.
6. Evoli A, Tonali PA, Padua L, Monaco ML, Scuderi F, Batocchi A P, Marino M, Bartoccioni E: Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis. Brain 2003;126: 2304-2311.
7. Sanders DB, El-Salem K, Massey JM, McConville J, Vincent A: Clinical aspects of MuSK antibody positive seronegative MG. Neurology 2003;60:1978-1980.
8. Bartoccioni E, Scuderi F, Minicuci GM, Marino M, Ciaraffa F, Evoli A: Anti-MuSK antibodies: correlation with myasthenia gravis severity. Neurology 2006;67:505-507.
9. Zhou L, McConville J, Chaudhry V, Adams RN, Skolasky RL, Vincent A, Drachman DB: Clinical comparison of muscle-specific tyrosine kinase (MuSK) antibody-positive and -negative myasthenic patients. Muscle Nerve 2004;30:55-60.
10. Stickler DE, Massey JM, Sanders DB: MuSK-antibody positive myasthenia gravis: clinical and electrodiagnostic patterns. Clin Neurophysiol 2005; 116:2065-2068.
11. Deymeer F, Gungor-Tuncer O, Yilmaz V, Parman Y, Serdaroglu P, Ozdemir C, Vincent A, Saruhan-Direskeneli G: Clinical comparison of anti-MuSK-vs anti-AchR-positive and seronegative myasthenia gravis. Neurology 2007;68:609-611.
12. Farrugia ME, Robson MD, Clover L, Anslow P, Newsom-Davis J, Kennett R, Hilton-Jones D, Matthews PM, Vincent A: MRI and clinical studies of facial and bulbar involvement in MuSK antibody-associated myasthenia gravis. Brain 2006;129:1481-1492.
13. Hatanaka Y, Hemmi S, Morgan MB, Scheufele ML, Claussen GC, Wolfe GI, Oh SJ: Nonresponsiveness to anticholinesterase agents in patients with MuSK-antibody-positive MG. Neurology 2005;65:1508-1509.
14. Caress JB, Hunt CH, Batish SD: Anti-MuSK myas thenia gravis presenting with purely ocular findings. Arch Neurol 2005;62:1002-1003.
15. Selcen D, Fukuda T, Shen X-M, Engel AG: Are MuSK antibodies the primary cause of myasthenic symptoms? Neurology 2004;62:1945-1950.
16. Oh SJ, Hatanaka Y, Hemmi S, Young AM, Scheufele ML, Nations SP, Lu L, Claussen GC, Wolfe GI: Repetitive nerve stimulation of facial muscles in MuSK antibody-positive myasthenia gravis. Muscle Nerve 2006;33:500-504.
17. Costa J, Evangelista T, Conceição I, de Carvalho M: Repetitive nerve stimulation in myasthenia gravis -Relative sensitivity of different muscles. Clin Neurophysiol 2005;115:2776-2782.
18. Nemoto Y, Kuwabara S, Misawa S, Kawaguchi N, Hattori T, Takamori M, Vincent A: Patterns and severity of neuromuscular transmission failure in seronegative myasthenia gravis. J Neurol Neurosurg Psychiatry 2005;76:714-718.
19. Farrugia ME, Kennett RP, Newsom-Davis J, Hilton-Jones D, Vincent A: Single-fiber electromyography in limb and facial muscles in muscle-specific kinase antibody and acetylcholine receptor antibody myas-thenia gravis. Muscle Nerve 2006;33:568-570.
20. Kuwabara S, Nemoto Y, Misawa S, Takahashi H, Kawaguchi N, Hattori T: Anti-MuSK-positive myasthenia gravis: neuromuscular transmission failure in facial and limb muscles. Acta Neurol Scand 2007; 115:126-128.
21. Oh SJ, Kim DE, Kuruoglu R, Bradley R, Dwyer D: Diagnostic sensitivity of laboratory tests in myasthenia gravis. Muscle Nerve 1992;15:720-724.
22. Padua L, Tonali P, Aprile I, Caliandro P, Bartoccioni E, Evoli A: Seronegative myasthenia gravis: comparison of neurophysiological picture in MuSK+ and MuSK- patients. Eur J Neurol 2006;13:273-276.
23. Farrugia ME, Kennett R P, Hilton-Jones D, Newsom-Davis J, Vincent A: Quantitative EMG of facial muscles in myasthenia patients with MuSK antibodies. Clin Neurophysiol 2007;118:269-277.
24. Lauriola L, Ranelletti F, Maggiano N, Guerriero M, Punzi C, Marsili F, Bartoccioni E, Evoli A: Thymus changes in anti-MuSK-positive and -negative myasthenia gravis. Neurology 2005;64:536-538.
25. Leite MI, Ströbel P, Jones M, Micklem K, Moritz R, Gold R, Niks EH, et al: Fewer thymic changes in MuSK antibody-positive than in MuSK antibodynegative MG. Ann Neurol 2005;57:444-448.
26. Saka E, Topcuoglu MA, Akkaya B, Galati A, Onal MZ, Vincent A: Thymus changes in anti-MuSK-positive and -negative myasthenia gravis. Neurology 2005;65:782-783.
27. Soliven BC, Lange KJ, Penn AS, Younger D, Jaretzki A III, Lovelace RE, Rowland LP: Seronegative myasthenia gravis. Neurology 1988;38:514-517.
28. Shiraishi H, Motomura M, Yoshimura T, Fukudome T, Fukuda T, Nakao Y, Tsujihata M, Vincent A, Eguchi K: Acetylcholine receptors loss and postsynaptic damage in MuSK antibody-positive myasthenia gravis. Ann Neurol 2005;57:289-293.
29. Farrugia ME, Bonifati DM, Clover L, Cossins J, Beeson D, Vincent A: Effect of sera from AChR-antibody negative myasthenia gravis patients on AChR and MuSK in cell cultures. J Neuroimmunol 2007;187:136-144.
30. Lavrnic D, Losen M, Vujic A, De Baets M, Hajdukovic LJ, Stojanovic V, Trikic R, Djukic P, Apostolski S: The features of myasthenia gravis with autoantibodies to MuSK. J Neurol Neurosurg Psychiatry 2005;76:1099-1102.
31. Takahashi H, Kawaguchi N, Nemoto Y, Hattori T: High-dose intravenous immunoglobulin for the treatment of MuSK antibody-positive seronegative myasthenia gravis. J Neurol Sci 2006;247:239-241.
32. Punga AR, Flink R, Askmark H, Stålberg EV: Cholinergic neuromuscular hyperactivity in patients with myasthenia gravis seropositive for MuSK antibody. Muscle Nerve 2006;34:111-115.
33. Ponseti JM, Caritg N, Gamez J, Lopez-Cano M, Vilallonga R, Armengol M: A comparison of long-term post-thymectomy outcome of anti-AChR-pos-itive, anti-AChR-negative and anti-MuSK-positive patients with non-thymomatous myasthenia gravis. Expert Opin Biol Ther 2009;9:1-8.
34. Drachman DB, Jones RJ, Brodsky RA: Treatment of refractory myasthenia: 'rebooting' with high-dose cyclophosphamide. Ann Neurol 2003;53:29-34.
35. Hain B, Jordan K, Deschauer M, Zierz S: Successful treatment of MuSK antibody-positive myasthenia gravis with rituximab. Muscle Nerve 2006;33:575-580.
36. Lin PT, Martin BA, Weinacker AB, So YT: High-dose cyclophosphamide in refractory myasthenia gravis with MuSK antibodies. Muscle Nerve 2006; 33:433-435.
37. Sanders D, Massey J, Juel V: MuSK antibody positive myasthenia gravis: response to treatment in 31 patients (abstract). Neurology 2007;68(suppl 1): A299.
38. Pasnoor M, Wolfe G, Nations S, Trivedi J, Barohn R, Herbelin L, et al: Clinical findings in MuSK-antibody positive myasthenia gravis (abstract). Neurology 2007;68:A299.
39. Zinman L, Ng E, Bril V: IV immunoglobulin in patients with myasthenia gravis: a randomized controlled study. Neurology 2007;68:837-841.
40. Diaz-Manera J, Rajas-Garcia R, Juarez C, Pradas J, Gallardo E, Illa I: Are immunosuppressors as effective in MuSK+ MG as in AChR+ MG patients? Evaluation of 150 myasthenic patients treated with the same protocol (abstract). Neurology 2007;68: A300.